Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 50mg+20mg

Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 50mg+20mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets (50mg+20mg)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

• Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets (50mg+20mg)
  Each film coated modified release tablet contains:
  Metoprolol Succinate IP                         (47.5mg)
  Equivalent to Metoprolol Tartrate…………50mg
  (As extended release form)
  Olmesartan Medoxomil IP……………………20mg
  Colour: Quinoline Yellow WS

THERAPEUTIC INDICATIONS:

Olmesartan Medoxomil + Metoprolol Succinate is used in the treatment of Hypertension (high blood pressure). Olmesartan Medoxomil + Metoprolol Succinate is a combination of two blood-pressure lowering medicines: Olmesartan Medoxomil and Metoprolol Succinate. Olmesartan Medoxomil is an angiotensin receptor blocker (ARB).

CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.

SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.

Dosage: As directed by the Physician.

Introduction to Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 50mg+20mg

What is Metoprolol Succinate (ER) & Olmesartan Medoxomil?

This combination tablet is designed to provide long-duration blood pressure control. The Metoprolol component ensures sustained release (ER), maintaining consistent blood levels over 24 hours. The Olmesartan component complements the effect by preventing vasoconstriction.

Key Uses:

• Hypertension (primary and resistant cases)

• Prevention of future cardiovascular events

• Reduced risk of heart failure progression

• Kidney protection in hypertensive patients

Global Demand

With >1.3 billion people affected by hypertension globally, this FDC has become one of the most imported antihypertensive formulations worldwide, especially in:

• African Union (AU) countries

• Gulf nations

• LATAM markets

• Asian developing economies

International buyers prefer WHO-GMP certified Indian manufacturers, and Taj Pharma leads this segment due to quality consistency and competitive pricing.

 In-Depth Details for Importers / Exporters / Global Buyers

International buyers sourcing Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 50mg+20mg from Taj Pharma receive end-to-end regulatory, documentation, and supply chain assistance.

 Regulatory Documentation Provided

Taj Pharma provides complete exporting and regulatory support, including:

• WHO-GMP Certificate

• EU-GMP (where required)

• Certificate of Pharmaceutical Product (COPP)

• CTD / ACTD Dossier

• DMF (as applicable)

• COA (certificate of analysis)

• MOA, stability data, and Method of validation

• MSDS

• Free Sale Certificate

• Manufacturing License

• Batch Manufacturing Records

This makes the product eligible for submission in tenders, regulatory approvals, PCD distributions, and government health programs.

Custom Packaging & Labelling

Taj Pharma offers:

• Private Label / OEM Manufacturing

• Custom logos, brand names, and packaging designs

• Child-resistant or blister/sachet/pouch packing

• Export-grade outer cartons

• Multi-language printing (English/French/Spanish/Arabic/Russian/Swahili)

Packaging available:

• Alu-Alu blister

• PVC-Blister

• HDPE bottles

• Bulk containers for institutional supply

 Shelf Life, Storage, Dosage Form

• Dosage Form: Extended-release film-coated tablet

• Strength: 50mg Metoprolol Succinate (ER) + 20mg Olmesartan Medoxomil

• Shelf Life: 24–36 months

• Storage: Store below 25°C, protect from moisture/light

• Pharmacopoeia: IP/USP/EP (as required)

 Export Certifications

Taj Pharma is a certified manufacturer holding:

• WHO-GMP

• GLP

• ISO 9001:2015

• ISO 14001

• OHSAS 18001

• FDA-Approved Manufacturing Plants

This makes Taj Pharma the first choice for Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 50mg+20mg export from India.

Target Countries & Export Markets

Taj Pharma exports across 80+ countries, including:

• Gulf: UAE, Saudi Arabia, Oman, Kuwait, Qatar

• Africa: Kenya, Nigeria, Tanzania, Ghana, Uganda, Ethiopia

• Asia: Vietnam, Philippines, Myanmar, Afghanistan, Sri Lanka

• CIS: Uzbekistan, Kazakhstan, Tajikistan

• LATAM: Peru, Chile, Bolivia

• Europe & Eastern Europe: Belarus, Georgia, Armenia

Taj Pharma is among the most preferred suppliers in government tenders due to stable pricing and reliable dispatch timelines.

Why Taj Pharma is the Most Trusted Manufacturer / Supplier / Exporter

1. State-of-the-Art WHO-GMP Manufacturing Facilities

Taj Pharma’s Vapi (Gujarat) manufacturing plant is equipped with:

• Modern granulation and compression systems

• Automated blister/bottle packaging lines

• ZLD waste management

• HVAC-controlled cleanroom environments

• Digitized batch monitoring

Every batch of Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 50mg+20mg undergoes 36+ QC tests.

2. Affordable Pricing and Strict Quality Assurance

Taj Pharma follows:

• Cost-effective bulk procurement

• International pharmacopoeia compliance

• Three-tier quality auditing

This ensures competitive pricing, making Taj Pharma the most demanded Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets manufacturer & supplier in India.

 3. Global Presence & Strong Supply Chain

Taj Pharma maintains:

• Multi-warehouse export hubs

• 24–72 hour dispatch timelines

• Temperature-controlled logistics

• Assurance against stockouts

Global buyers rate Taj Pharma highly for fast response, documentation accuracy, and uninterrupted supply.

 4. Top 20 Countries 

Nigeria | Kenya | Ghana | Tanzania | Uganda | Myanmar | Vietnam | Philippines | Yemen | Afghanistan | Iraq | Iran | Peru | Bolivia | Chile | Mexico | Dominican Republic | Nepal | Cambodia |Ethiopia

Technical Product Specification Table

Call to Action 

Importers, distributors, PCD franchise owners, and government procurement agencies seeking a reliable source of Metoprolol Succinate (ER) & Olmesartan Medoxomil Tablets 50mg+20mg can connect with Taj Pharma for quotations, regulatory files, or bulk orders.

Contact Taj Pharma Today:
📧  info@tajpharma.com
🌐 www.tajpharma.com
📍 Vapi, Gujarat – India’s Leading Pharmaceutical Hub

Get the best price, fastest delivery, and unmatched regulatory support.

Top 20 FAQs 

1. What is Metoprolol Succinate (ER) & Olmesartan Medoxomil 50mg+20mg used for?

It is used to treat hypertension, reduce heart workload, and prevent cardiovascular events.

2. Is this combination safe for long-term use?

Yes, when prescribed by a physician.

3. Who manufactures this tablet in India?

Taj Pharma is among the leading WHO-GMP-certified manufacturers.

4. Can I take these tablets with food?

Yes, they may be taken with or without food.

5. What are the common side effects?

Dizziness, weakness, fatigue, low blood pressure, nausea.

6. Is dizziness normal after taking it?

Yes. Patients should rise slowly from sitting/lying positions.

7. Do you export globally?

Yes—over 80+ countries.

8. Can buyers request custom branding?

Yes, OEM/contract manufacturing is available.

9. What is the minimum order quantity?

MOQ varies by buyer type; export MOQ is generally one commercial lot.

10. Is CTD dossier available?

Yes, full CTD/ACTD documentation is provided.

11. Is the product WHO-GMP certified?

Yes, Taj Pharma’s facility is WHO-GMP approved.

12. Do you supply to government tenders?

Yes, Taj Pharma is a preferred tender supplier.

13. What pharmacopoeia standards are available?

IP/USP/EP depending on buyer requirement.

14. What is the lead time for export?

Usually 2–3 weeks depending on order size.

15. Can I order trial samples?

Yes, samples are provided to qualified buyers.

16. Is stability data included?

Yes, zone-wise stability documentation is available.

17. Is the formulation effective for resistant hypertension?

Yes, physicians often use this FDC in complex cases.

18. Can the tablets be crushed?

No—extended-release tablets must be swallowed whole.

19. Do you support product registration?

Yes, full regulatory support is available.

20. How can I get a quote?

Contact Taj Pharma via email or website for pricing.